374 related articles for article (PubMed ID: 6276943)
1. [Current therapeutic aspects of myasthenia gravis].
Avilés Mejias S; Ledro Molina D; Garrido Peralta M
Rev Clin Esp; 1981 Oct; 163(2):139-44. PubMed ID: 6276943
[No Abstract] [Full Text] [Related]
2. [Therapies of myasthenia gravis (author's transl)].
de Crousaz G
Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937
[No Abstract] [Full Text] [Related]
3. [Immunosuppressive therapy of myasthenia gravis].
Lechner H; Ott E; Aranibar A
Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
[No Abstract] [Full Text] [Related]
4. Thymoma, myasthenia gravis, and other paraneoplastic syndromes.
Tormoehlen LM; Pascuzzi RM
Hematol Oncol Clin North Am; 2008 Jun; 22(3):509-26. PubMed ID: 18514130
[TBL] [Abstract][Full Text] [Related]
5. [Thymus and myasthenia].
de Crousaz G; Zoupanos G
Rev Med Suisse Romande; 1973 Feb; 93(2):143-58. PubMed ID: 4704793
[No Abstract] [Full Text] [Related]
6. [Myasthenia gravis. Recent findings and their therapeutic consequences].
Thümler R; Haferkamp G
Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
[No Abstract] [Full Text] [Related]
7. [Therapy of myasthenia gravis].
Jerusalem F
Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
[No Abstract] [Full Text] [Related]
8. [The current status of the problem of treating myasthenia].
Lobzin VS
Vopr Psikhiatr Nevropatol; 1968; 13():640-8. PubMed ID: 4906476
[No Abstract] [Full Text] [Related]
9. [Myasthenia gravis. Immunosuppressive treatment].
Horn J
Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
[No Abstract] [Full Text] [Related]
10. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
11. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
Ghezzi M; Taiuti R; Marconi G
Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis, diagnosis, and treatment of myasthenia (review of the foreign literature)].
Vasil'ev VN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(11):1729-34. PubMed ID: 7006280
[No Abstract] [Full Text] [Related]
13. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
[No Abstract] [Full Text] [Related]
14. [Treatment of myasthenia].
Goulon M; Estournet B; Gajdos P
Rev Prat; 1979 Jun; 29(35):2789-99. PubMed ID: 493836
[No Abstract] [Full Text] [Related]
15. [Aplastic anemia in thymoma].
Seewann HL; Wascher H; Wagner K; Fladerer H
Med Klin; 1972 Nov; 67(45):1477-9. PubMed ID: 4637697
[No Abstract] [Full Text] [Related]
16. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
Ricken D
Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360
[No Abstract] [Full Text] [Related]
17. The treatment of patients with myasthenia gravis.
Sanders DB; Scoppetta C
Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of myasthenia gravis].
Matell G; von Reis G
Lakartidningen; 1973 Oct; 70(43):3821-5. PubMed ID: 4362569
[No Abstract] [Full Text] [Related]
19. Myasthenia gravis: clinical, immunological, and therapeutic advances.
Romi F; Gilhus NE; Aarli JA
Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
[TBL] [Abstract][Full Text] [Related]
20. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
Tindall RS
Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
